| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.002 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |